Serve Robotics vs Teradyne: Which Robotics Stock Is a Buy For 2026?

Serve Robotics reported Q3 2025 revenue of $687,000 (up 209% YoY) as deployments surpassed 1,000 robots and delivery volume rose 300% YoY, but posted a Q3 gross loss of $4.4M and an operating loss of $34.8M with guidance to reach 2,000 robots by end-2025 and an expected 10x revenue jump in 2026; consensus EPS losses widened to ($1.55) for 2025 and are projected at ($1.72) for 2026. Teradyne delivered Q3 2025 revenues of $769M (up 4% YoY) with Semiconductor Test at $606M, cited surging AI-driven test demand and memory (HBM/DRAM) strength, expects Q4 revenue ~25% sequentially higher, saw 2025 EPS estimates raised from $3.14 to $3.51 and projected ~45% EPS growth in 2026; valuation contrast: SERV forward P/S ~36.77x vs TER ~7.66x (sector 6.66x).

Analysis

Market structure: Teradyne (TER) is a clear near-term winner — Q3 revenue $769M with $606M from semiconductor test and management guiding +25% sequential in Q4 — giving it immediate pricing power and backlog that tightens supply for high‑end test systems (UltraFLEXplus, HBM inserts). Serve Robotics (SERV) is a niche growth story (1,000 robots, Q3 rev $0.687M, target 2,000 by end‑2025) but faces weak pricing power, high capital intensity and municipal/regulatory friction that compress margins and shift competitive share toward deep‑pocket partners (Uber/DoorDash, Magna).

Risk assessment: Key tail risks include a semiconductor capex pullback (order cancellations that could cut TER revenue growth >20% in a quarter), export controls on advanced test equipment, and for SERV, regulatory bans or high liability costs in major metros that could double opex per unit. Time horizons split: immediate (days) — TER earnings/guide volatility and option IV spikes; short (weeks–months) — order book realization and Serve deployment cadence; long (quarters–years) — SERV dilution/cash runway vs TER secular AI test intensity sustaining 2026+ margins.

Trade implications: Prefer high‑conviction long TER exposure and avoid/short SERV until proof of sustainable unit economics; consider pair trades long TER/short SERV to capture divergence in forward PS (7.66x vs 36.77x). Use options: buy TER call spreads into next quarterly (capture upside while capping cost) and buy long‑dated SERV puts or structured collars to protect against dilution and milestone misses. Rotate portfolio + overweight semicap test equipment and memory/HBM suppliers, underweight early‑stage robotics hardware until SERV shows positive gross margin over two consecutive quarters.

Contrarian angles: Consensus underprices execution and regulatory risk for SERV and may be overpaying for optionality — an 800% revenue forecast for 2026 requires near‑perfect scaling and no material price cuts. Conversely, TER’s strength could be underowned if AI chip test intensity persists; a 20–30% upside remains if Q4 orders exceed guidance. Historical parallel: semicap booms often overshoot then snap back; monitor order cancellations and lead‑time compression as early warning signals that could reverse TER’s run.

Key Decisions for Investors

• Establish a 1.5–2.5% portfolio long position in TER within 1–3 weeks, using a 6–9 month horizon; hedge 25% of position with 3–4 month OTM (10–15% delta) put protection if TER drops >12% intraday on guidance miss.
• Initiate a small tactical short or avoid SERV: size <=0.5% of portfolio or buy 9–12 month puts (LEAPS) strike ~10–20% OTM, because SERV trades at 36.8x forward PS with widening losses; increase short if SERV fails to deploy 2,000 robots by EOY 2025 or posts another >15% quarter‑over‑quarter gross loss.
• Execute a pair trade: long TER (2%) funded by short SERV (0.75%) to capture relative convergence; target P/L: take half profits on 20% absolute gain in TER or if TER forward EPS revisions stall; cover short SERV if cash runway extends beyond 18 months without dilution.
• Buy a TER call spread (buy 6‑month 1.1× forward strike, sell 1.25× strike) sized at 0.5–1% notional to exploit expected Q4 order strength while limiting premium outlay; unwind if implied vol rises >30% vs 30‑day average.
• Reduce generic 'early‑stage robotics' exposure by 50bps across portfolio and rotate into semicap beneficiaries (TER, memory test suppliers) over next 30–90 days; re‑assess SERV only after two consecutive quarters of positive gross margin and confirmed non‑dilutive funding.